Trials find the drug doubles the risk of leg and foot amputation In a recent communication, the U.S. Food and Drug Administration (FDA) warned patients that taking the type 2 diabetes drug canagliflozin (Invokana, Invokamet, Invokamet XR) can cause an increased risk of leg and foot amputations. The FDA says patients taking Invokana and similar drugs should notify their doctor as soon as possible if they find new pain and tenderness in their feet and legs. Invokana and Invokamet are...Continue Reading
Scientists at Yale find approval not a guarantor of drug safety Researchers at the Yale School of Medicine have published a 2017 report showing that of 222 drugs the U.S. Food and Drug Administration (FDA) approved between 2001 and 2010, 71 were affected by safety events after they had already been sold to patients. Dr. Joseph Ross and his colleagues studied the FDA’s approval process for new drugs and found that the median time from the FDA’s approval of the...Continue Reading
Over 18,000 patients accuse Johnson & Johnson and Bayer of failing to inform doctors about the dangers of the blood-thinning drug. On April 24th, a bellwether trial began in the lawsuit against the stroke drug, Xarelto, manufactured by Johnson & Johnson and Bayer. The plaintiffs accuse the pharmaceutical companies of failing to provide sufficient information about the risks involved in taking Xarelto, including what the plaintiffs claim is a high chance for severe bleeding events. The Chicago Tribune reports that...Continue Reading
The Military Times recently reported on the case of Sgt. 1st Class Cameron Corder, a soldier who broke his back in a helicopter accident in Afghanistan in 2013. Corder, a Michigan native and army medic, was treating a Marine injured in an IED blast when his injury happened. The Marine that Corder was treating, likely suffering shock, became aggressive inside the helicopter and tackled Corder to the floor. Corder says that he fell into medical equipment inside the helicopter and...Continue Reading
The World Health Organization’s (WHO) International Agency for Research on Cancer (IARC) has been under fire lately after a controversial finding that the world’s leading herbicide, glyphosate, is “probably carcinogenic.” Criticism of the agency, including the charge that they are sometimes too hasty in concluding that a substance is carcinogenic, has led to some U.S. lawmakers calling into question the U.S. funding of the WHO program. Groups like CropLife America have been standard-bearers for criticism of the agency, alleging that...Continue Reading
Speak with a Lawyer
Contact an attorney today for a free and confidential legal consultation.